443 results
Page 4 of 23
424B3
lmcy67
27 Dec 21
Prospectus supplement
5:01pm
UPLOAD
y8lg3qco g692
21 Dec 21
Letter from SEC
12:00am
8-K
EX-10.1
j89w wgohy04a
24 Nov 21
Seelos Therapeutics Announces Acquisition of an Exclusive License of iX Biopharma’s Proprietary Wafer-Based Delivery Platform for Sublingual Ketamine
8:20am
8-K
EX-10.2
ucbu9gcr9hs3h
24 Nov 21
Entry into a Material Definitive Agreement
7:27am
424B5
31v80hxts pjayeu
21 May 21
Prospectus supplement for primary offering
12:00am
8-K
EX-1.1
5g8i ibb8r
21 May 21
Seelos Therapeutics Announces Pricing of $60 Million Public Offering of Common Stock
12:00am
424B5
q5qm9r yn
19 May 21
Prospectus supplement for primary offering
4:08pm